258 filings
Page 8 of 13
8-K
aa9oivqgwxje2 bokjel
8 May 17
Acceleron Pharma Reports First Quarter 2017 Operational and Financial Results
12:00am
8-K
2skt72yt7
2 May 17
Departure of Directors or Certain Officers
12:00am
8-K
q82x8f2j8ux58v
27 Apr 17
Acceleron Provides Clinical Development Updates on Luspatercept Program
12:00am
DEFA14A
b3gvsqo7i1qwa vkc
13 Apr 17
Additional proxy soliciting materials
12:00am
CT ORDER
iw5 01tf8it
22 Mar 17
Confidential treatment order
12:00am
8-K
mvisspg w7ficiac7
1 Mar 17
Acceleron Reports Fourth Quarter and Year Ended 2016 Operational and Financial Results
12:00am
8-K
5vsd ec5ka
9 Jan 17
Regulation FD Disclosure
12:00am
8-K
qgfapbbt
7 Dec 16
Other Events
12:00am
8-K
26wcrq3ysg9f
3 Nov 16
Acceleron Pharma Reports Third Quarter 2016 Financial and Operational Results
12:00am
8-K
geit7z0 pbnesh0w
27 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
2xa5i xkbuh
12 Sep 16
Amendments to Articles of Incorporation or Bylaws
12:00am
CT ORDER
on4q7uqx wkew0bg8d11
8 Aug 16
Confidential treatment order
12:00am
8-K
nst175v
4 Aug 16
Acceleron Pharma Reports Second Quarter 2016 Financial and Operational Results
12:00am
8-K
q3kvo0
25 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
2mebt499
11 Jul 16
Acceleron Announces ACE-083 Phase 1 Results at the 14th International Congress on Neuromuscular Diseases
12:00am